Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-01-30 @ 11:04 PM
Study NCT ID:
NCT01947868
Status:
COMPLETED
Last Update Posted:
2016-09-23
First Post:
2013-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor
Sponsor:
AstraZeneca
Organization: